Global Antibiotics Market Size study, by Action Mechanism (Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, and Mycolic Acid Inhibitors) Drug Class (Cephalosporin, Penicillin, Fluoroquinolone, Macrolide, Carbapenem, Aminoglycoside, Sulfonamide, and 7-ACA) and Regional Forecasts 2021-2027

  • Product Code:
    RP-ID-10347675
  • Published Date:
    17 Jul 2021
  • Region:
    Global
  • Pages:
    200
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-14

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

Global Antibiotics Market is valued approximately USD 40.85 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 4.6 % over the forecast period 2021-2027. Antibiotics are the anti-microbial that destroy or slows down the growth of bacteria. Antibiotics are available in different forms like pills, capsules, syrups or injections. The increasing investments in research and development of new antibiotic drugs, increasing growth in the incidences of infection and chronic diseases and constant support from the governments for the development of antibacterial drugs have been driving the global market across the forecast period. There have been continuous efforts of pharmaceutical companies in development of new antibiotics which are more susceptible in nature. According to a report published by Proceedings of the National Academy of Science (PNAS), the consumption rate of antibiotics increased by 39% during the period of 2000-2015, whichis further expected to increase by 200% by 2030. As per the report of World Health Organization (WHO), around 10 million cases of tuberculosis were diagnosed in 2019, leading to increased consumption of antibiotics. However, strict government regulations for the approval of new medicines and certain side effects of antibiotics can hamper the growth of the market over the forecast period of 2021-2027. Whereas, prolonged increase in the demand of antibiotics is likely to increase the market growth during the forecast period.

The regional analysis of global Natural Extracts market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia-Pacific holds the largest market share. This is mainly because of an increase in the number of prescriptions of antibiotics as well as the larger population in the region. Whereas, North America is also expected to project remarkable growth over the upcoming period 2021-2027. Factors such as the availability of many pharmaceutical manufacturers and improving healthcare infrastructure would help North America to outpace the Antibiotics Market.

Major market player included in this report are:
Allergan (AbbVie Inc.)
Merck & Co., Inc
Cumberland Pharmaceuticals, Inc.
GlaxoSmithKline plc
Novartis AG
Melinta Therapeutics
Teva Pharmaceutical Industries Ltd.
Nabriva Therapeutics plc
Mylan N.V.
Abbott Laboratories

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Action Mechanism:
Cell Wall Synthesis Inhibitors
Protein Synthesis Inhibitors
DNA Synthesis Inhibitors
RNA Synthesis Inhibitors
Mycolic Acid Inhibitors
Others
By Drug Class:
Cephalosporin
Penicillin
Fluoroquinolone
Macrolide
Carbapenem
Aminoglycoside
Sulfonamide
7-ACA
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027

Target Audience of the Global Antibiotics Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth Market Players Analys  & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  •  Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth Market Players Analysis & Opportunity Outlook
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Antibiotics Market, by Region, 2019-2027 (USD Billion)
1.2.2. Antibiotics Market, by Action Mechanism, 2019-2027 (USD Billion)
1.2.3. Antibiotics Market, by Drug Class, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Antibiotics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Antibiotics Market Dynamics
3.1. Antibiotics Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Investments in research and development of new antibiotic drugs
3.1.1.2. Increasing growth in the incidences of infection and chronic diseases
3.1.1.3. Constant support from the governments
3.1.2. Market Challenges
3.1.2.1. Strict government regulations for the approval of new medicines
3.1.2.2. Certain side effects of antibiotics
3.1.3. Market Opportunities
3.1.3.1. Prolonged increase in the demand of antibiotics
Chapter 4. Global Antibiotics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Antibiotics Market, by Action Mechanism
5.1. Market Snapshot
5.2. Global Antibiotics Market by Action Mechanism , Performance - Potential Analysis
5.3. Global Antibiotics Market Estimates & Forecasts by Action Mechanism 2018-2027 (USD Billion)
5.4. Antibiotics Market, Sub Segment Analysis
5.4.1. Cell Wall Synthesis Inhibitors
5.4.2. Protein Synthesis Inhibitors
5.4.3. DNA Synthesis Inhibitors
5.4.4. RNA Synthesis Inhibitors
5.4.5. Mycolic Acid Inhibitors
5.4.6. Others
Chapter 6. Global Antibiotics Market, by Drug Class
6.1. Market Snapshot
6.2. Global Antibiotics Market by Drug Class, Performance - Potential Analysis
6.3. Global Antibiotics Market Estimates & Forecasts by Drug Class 2018-2027 (USD Billion)
6.4. Antibiotics Market, Sub Segment Analysis
6.4.1. Cephalosporin
6.4.2. Penicillin
6.4.3. Fluoroquinolone
6.4.4. Macrolide
6.4.5. Carbapenem
6.4.6. Aminoglycoside
6.4.7. Sulfonamide
6.4.8. 7-ACA
6.4.9. Others
Chapter 7. Global Antibiotics Market, Regional Analysis
7.1. Antibiotics Market, Regional Market Snapshot
7.2. North America Antibiotics Market
7.2.1. U.S. Antibiotics Market
7.2.1.1. Action Mechanism breakdown estimates & forecasts, 2018-2027
7.2.1.2. Drug Class breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Antibiotics Market
7.3. Europe Antibiotics Market Snapshot
7.3.1. U.K. Antibiotics Market
7.3.2. Germany Antibiotics Market
7.3.3. France Antibiotics Market
7.3.4. Spain Antibiotics Market
7.3.5. Italy Antibiotics Market
7.3.6. Rest of Europe Antibiotics Market
7.4. Asia-Pacific Antibiotics Market Snapshot
7.4.1. China Antibiotics Market
7.4.2. India Antibiotics Market
7.4.3. Japan Antibiotics Market
7.4.4. Australia Antibiotics Market
7.4.5. South Korea Antibiotics Market
7.4.6. Rest of Asia Pacific Antibiotics Market
7.5. Latin America Antibiotics Market Snapshot
7.5.1. Brazil Antibiotics Market
7.5.2. Mexico Antibiotics Market
7.6. Rest of The World Antibiotics Market

Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Allergan (AbbVie Inc.)
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Merck & Co., Inc
8.2.3. Cumberland Pharmaceuticals, Inc.
8.2.4. GlaxoSmithKline plc
8.2.5. Novartis AG
8.2.6. Melinta Therapeutics
8.2.7. Teva Pharmaceutical Industries Ltd.
8.2.8. Nabriva Therapeutics plc
8.2.9. Mylan N.V.
8.2.10. Abbott Laboratories
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
Allergan (AbbVie Inc.)
Merck & Co., Inc
Cumberland Pharmaceuticals, Inc.
GlaxoSmithKline plc
Novartis AG
Melinta Therapeutics
Teva Pharmaceutical Industries Ltd.
Nabriva Therapeutics plc
Mylan N.V.
Abbott Laboratories
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports